In a first-of-its-kind study, Cornell researchers modeled how a gene drive would proceed in plants. Their simulations suggest that a gene drive’s success may hinge on seed banks – underground ...

Any molecular biologist will tell you that genetic engineering is tricky. But up until recently we might be witnessing a new ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

A mystery surrounding why powerful gene-editing technology that has driven major advances in medicine over the past decade can sometimes make mistakes, has been solved with the help of scientists from ...

Scientists from the University of Sheffield, the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have helped solve a decade-long ...

Researchers have found that certain bacteria carry a naturally occurring system, built from repurposed CRISPR components, ...

In a decision announced today (March 26), the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (USPTO and ...

CRISPR is a powerful DNA-editing tool that has underpinned huge advancements in human health care in the last decade. It is a ...

Researchers revealed a CRISPR system that activates gene expression rather than cutting DNA, using RNA-guided targeting. The ...

In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia. "We didn't know that we ...